Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiodoron for functional cardiovascular disorders
2024-511210-21-00Phase 4Completed
- Sponsor
- Weleda
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Functional Cardiovascular Disorder (FCD) comparing Cardiodoron with Placebo (2 arms). Started Jul 2024; status: completed.
02
Drugs
Cardiodoron
03
Conditions
Functional Cardiovascular Disorder (FCD)
Beyond the preview
Go deeper on 2024-511210-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511210-21-00.